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The age-related risk of disease following Mycobacterium tuber-culosis infection is greatest in children <4 years, reaches a 
nadir in those between 5 and 10 years and increases rapidly dur-
ing adolescence.1 In infants and toddlers, extrapulmonary disease 
including tuberculous meningitis or miliary tuberculosis is com-
mon and in adolescence a shift of pathology toward adult-type dis-
ease (ATD) is observed.2,3
Tissue destruction and lung cavitation hallmark ATD that 
may develop 1–3 years after primary M. tuberculosis infection.4 
Unrecognized ATD puts household members or school contacts at 
risk for tuberculosis.5 Rare reports on pediatric ATD in the chemo-
therapy era exclusively originate from regions with high tuberculo-
sis incidence.6–9 We aimed at reviewing pediatric ATD patients in a 
low tuberculosis incidence region to define the individuals at risk 
and to assess their transmission potential.
PATIENTS AND METHODS
Patients
A diagnosis code inquiry served to gather all patients <16 
years hospitalized because of tuberculosis at the University Chil-
dren’s Hospital of Zurich from 1990 through 2011. This period 
was chosen because of electronic availability of diagnosis codes. 
Demographic data were extracted by chart review and information 
on clinical, laboratory and imaging findings, diagnosis establish-
ment, treatment and course was retrieved for ATD patients. ATD 
was defined as the presence of a pulmonary cavity in imaging4 and 
detection of M. tuberculosis in sputum, gastric lavage (GL) or bron-
choalveolar lavage (BAL). The institutional review board approved 
the study.
Contact Investigations
The staff of the lung league prospectively investigated fam-
ily members and close contacts (> 8 hours cumulative exposure), 
both hereafter referred to as household contacts, plus school con-
tacts (classmates and teachers) of ATD patients based on Swiss 
law (http://www.admin.ch/ch/d/sr/818_101/a16.html). In clinically 
healthy individuals, investigations included a tuberculin skin test 
(TST) and, if induration was ≥5 mm, a chest X-ray, or if induration 
was < 5 mm, a second TST 8 weeks later. Individuals exposed to the 
source cases and showing positive TST (induration ≥ 5 mm) in the 
absence of physical findings of disease were regarded to have latent 
tuberculous infection (LTBI) if chest X-ray was normal or revealed 
evidence of healed infection. Data for this work were obtained from 
the records of the lung league.
Statistics
Independent t-test was performed for statistical calcula-
tions regarding age and exact Fisher’s test for those regarding sex 
unavailable. Health care providers in our region must consider Buruli 
ulcer in any patient with a suggestive lesion and either refer to a ter-
tiary care facility for diagnosis or initiate therapy accordingly.
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and immigrant background using IBM SPSS Statistics 21.0, 2012 
(Armonk, NY). P < 0.05 were regarded as statistically significant.
RESULTS
Patient Demographics
A total of 45 patients were hospitalized because of tubercu-
losis in our hospital within 1990–2011: 26 with pulmonary tuber-
culosis including 5 with ATD plus 19 with extrapulmonary tuber-
culosis including 2 with miliary tuberculosis and 5 with meningitis. 
Patients with ATD (median 13.2 years, range 12.4–16.2; cases 1–5, 
Table 1) were older than patients with non-ATD pulmonary tuber-
culosis (6.9, 0.1–19.4, P = 0.044) or extrapulmonary tuberculosis 
(1.8, 0.1–11.1, P < 0.05). The proportions with immigrant back-
ground were 100% for ATD (Table 1) and 72.5% for non-ATD 
tuberculosis or extrapulmonary tuberculosis (P = 0.31). There was 
no significant difference regarding sex distribution between ATD 
patients versus non-ATD pulmonary or extrapulmonary tubercu-
losis patients (P = 0.63). Three non-ATD pulmonary tuberculosis 
patients had congenital immunodeficiency (chronic granulomatous 
disease, Wiskott-Aldrich syndrome or Nezelof syndrome) and 1 
was HIV positive.
ATD case 2 travelled last to Pakistan 1 year before diagno-
sis, case 3 to Croatia 10 months before first symptoms and case 4 to 
Kosovo 8 and 3 years before diagnosis, respectively, and had often 
visits from Kosovo until diagnosis. Case 5 immigrated from Tibet 
10 months before diagnosis (Table 1).
Clinical Characteristics of ATD Patients
Cough, fever, night sweats, fatigue or weight loss were the 
main symptoms. The presenting symptoms at first physician con-
sultation had lasted < 2 months. Time from consultation to diag-
nosis was between <1 week and 6.5 months (Table 1). TST was 
positive in 3 patients (Table 1). HIV serology was not done in case 
2 and negative in the other cases.
Microbiological Findings
Acid-fast bacilli were detected by microscopy in sputum, 
BAL or GL in all ATD patients. M. tuberculosis grew in cultures 
from sputum (n = 4) or if not available from BAL (n = 1). The iso-
late of case 1 was isoniazid resistant.
Treatment and Course in ATD patients
Two patients received isoniazid, rifampin and pyrazinamide 
for 2 months followed by isoniazid and rifampin for 7 months. Two 
patients received isoniazid, rifampin, pyrazinamide and ethambutol 
for 2 months followed by isoniazid and rifampin for 4 months. One 
patient received isoniazid that was replaced by ciprofloxacin after 
3 weeks, rifampin, pyrazinamide and ethambutol for 2 months, fol-
lowed by ciprofloxacin and rifampin for 4 months because of iso-
niazid resistance.
Signs and symptoms improved during treatment in all 5 
patients. They were discharged in good general conditions after a 
mean hospitalization of 23.6 days (range, 14–28). Cases 1 and 5 
recovered completely. Cases 2 and 3 showed obstructive ventila-
tion 24 and 28 months, respectively, after ending treatment. Case 4 
showed restrictive and obstructive ventilation and growth retarda-
tion 4 years after ending treatment (Table 1). Chest X-rays at the 
end of treatment showed residual changes in all patients.
Contact Investigations
Information on contact investigations was not available for 
cases 1 and 2. For case 3, LTBI was diagnosed in 3 of 12 pediatric 
and 4 of 4 adult household contacts, 19 of 40 classmates and in 3 
of 15 teachers. For case 4, LTBI was diagnosed in all 5 pediatric 
and 1 of 2 adult household contacts and in 3 of 21 classmates and 
1 of 3 teachers. For case 5, LTBI was diagnosed in 4 of 6 pediatric 
and none of 4 adult household contacts, and in 1 of 20 classmates 
and none of 2 teachers. Isoniazid prophylaxis was recommended to 
all pediatric contacts with LTBI, but the proportion of those taking 
isoniazid is not known. No tuberculosis disease was diagnosed.
DISCUSSION
We delineated the characteristics of ATD patients and 
assessed their transmission potential in a low tuberculosis incidence 
region. We found that ATD patients were older than other pediatric 
hospitalized tuberculosis patients, had invariably immigrant family 
background, were generally successfully treated, although minor 
respiratory impairment was possible, and many of the close con-
tacts had LTBI.
One-tenth of the hospitalized pediatric tuberculosis patients 
showed ATD, and ATD patients were adolescents. Swiss law 
demands reporting and isolation of tuberculosis patients (practi-
cally always in hospital), as long as they are highly contagious, 
that is, they have detectable acid-fast bacilli in sputum or have not 
received effective antituberculous treatment for at least 2 weeks. 
ATD patients must be regarded as highly contagious.3 Thus, their 
outpatient treatment in the Swiss community is unlikely. Other pedi-
atric tuberculosis patients are rather hospitalized only when severe 
disease manifests. Thus, the proportion of ATD patients among all 
pediatric tuberculosis patients in Switzerland is likely to be less 
than the approximate 10% seen in this study. In tuberculosis high-
incidence regions, the proportion of ATD patients among pediatric 
tuberculosis patients was 12.8%.8 The age disparity among pediat-
ric patients with distinct tuberculosis disease manifestations in our 
hospitalized patients and Switzerland (Data, Supplemental Digital 
Content 1, http://links.lww.com/INF/B703) matches that reported 
from high-incidence regions.10
Four ATD patients had immigrated to Switzerland from 
high-incidence regions 10 months to 7 years before diagnosis of 
ATD. Case 3 was born in Switzerland and her parents were immi-
grants from a high-incidence country. Data from the Swiss Federal 
Office of Public Health for 1996–2011 show that 90.3% and 92.1% 
of reported tuberculosis cases in the age groups 10–14 and 15–19 
years, respectively, have an immigrant background (Data, Sup-
plemental Digital Content 1, http://links.lww.com/INF/B703) and 
thus a similar frequency. The natural history of tuberculosis disease 
indicates that adolescents are at high risk to develop ATD 1–3 years 
after primary infection or as a reactivation disease.4
None of our ATD patients was critically ill. All of them 
showed fast recovery after the start of efficacious drug therapy and 
limited respiratory sequelae. Similar data were reported from South 
Africa6,11 and Korea.7 These observations have at least 2 implica-
tions. First, ATD patients may escape diagnosis while highly con-
tagious, because their illness may not be impressive enough for an 
urgent work-up. This puts household and school contacts at sig-
nificant risk for infection with M. tuberculosis that may even be 
drug resistant as shown here and elsewhere.6 Notably, diagnosis 
in our case 3 was delayed over half a year and almost half of her 
school contacts had LTBI. Second, antibiogram-guided antituber-
culosis treatment leads to rapid reduction of contagiousness and 
cures ATD, albeit some impairment of lung function is possible as 
seen in our patients.
Our work has the limitations of a retrospective study that 
may miss data that are no longer retrievable and may suffer from 
information bias. The low number of patients with ATD may be 
regarded as limitation but this seems to be the reality of the situa-
tion in an industrialized country.
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Mendelian susceptibility to mycobacterial disease (MSMD) is a rare genetic disorder that carries an increased predis-
position to suffer nontuberculous mycobacteria (NTM), Bacille 
 Calmette-Guérin or Salmonella spp. infections in apparently 
healthy individuals.1 Interleukin-12 β1 receptor deficiency 
(IL12Rβ1) was the first MSMD defect reported and to date it is 
the most prevalent.2,3
Mycobacterium genavense’s ability to cause disease in 
humans is extremely rare and probably underestimated due to 
its slow and fastidious growing characteristics. NTM infec-
tions have been classically described in HIV-infected patients.4 
Recently, advances in antiretroviral therapy have been able to 
reduce the incidence of opportunistic infections like NTM.5 
However, new cases are emerging associated with newly diag-
nosed primary immunodeficiencies.4 On the other hand, other 
NTM such as Mycobacterium fortuitum have been associated 
with skin infections secondary to trauma or surgical procedures, 
traumatic ulcers, corneal keratitis, lung disease, lymphadenitis 
or osteomyelitis.6
CASE REPORTS
The first patient, who was a 5-year-old Caucasian female 
born in Spain to consanguineous parents (first cousins), was 
admitted to Torrecardenas Hospital (Almeria, Spain) in Febru-
ary 2010 with diarrhoea, bloating, fever mostly in the evenings 
and weight loss during the previous 9 months. Physical exami-
nation revealed severe abdominal distension although nontender 
to palpation, splenomegaly and moderate malnutrition. Serolog-
ical tests for Mycoplasma pneumoniae, Chlamydia pneumoniae, 
Epstein-Barr virus, Coxiella burnetti, Cytomegalovirus, toxo-
plasma, viral hepatitis, HIV and tuberculosis skin test were all 
negative. Gastrointestinal endoscopy was performed revealing 
chronic granulomatous colitis with abundant acid-fast bacilli 
that did not grow in standard culture conditions (Lowenstein-
Jensen and BACT/Alert MP media). The bacilli was identi-
fied as M. genavense directly from the specimen by amplifica-
tion and sequencing of 366 bp of the hsp65 gene, obtaining a 
100% alignment with the M. genavense sequences AJ310235, 
AF547837 and AB292585 deposited in GenBank. Given these 
findings, the patient was started on treatment with rifampicin, 
clarithromycin, ethambutol and levofloxacin (these last 2 anti-
biotics were replaced by amikacin and ciprofloxacin due to 
persistent infection after 10 months of treatment). Six months 
later the patient was readmitted on 2 occasions after develop-
ing Salmonella enteritidis sepsis confirmed by blood and stool 
cultures. Peripheral blood mononuclear cells (PBMCs) obtained 
from the patient were cultured in vitro with Phytohemagglutinin 
(PHA; GIBCO#cat: 10576-015) at 1.5% for 72 hours. Super-
nadants were collected to measure cytokine levels and lympho-
cytes were stained with CD212-PE, CD3 PercP and  CD25-FITC 
and analyzed by flow cytometry. CD212 (IL12Rβ1) expression 
was absent in the patient. Sequencing analysis of IL12Rβ1 gene 
showed a novel homozygous deletion (g.1019_1020delAC) 
affecting codon His-339 in exon 9 and resulting in a frame 
shift mutation, not previously described. Given the definitive 
Adolescents with immigrant background from regions with 
higher tuberculosis incidence than in Switzerland are more likely 
to present with ATD in low-incidence regions. Antituberculosis 
drugs resolve ATD although respiratory sequelae are possible. 
Most importantly, ATD patients may escape recognition and—if 
treatment is delayed—significant transmission of M. tuberculosis 
to close contacts may take place due to the high contagiousness.
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DIFFERENT PENETRANCE OF DISSEMINATED 
INFECTIONS CAUSED BY NONTUBERCULOUS 
MYCOBACTERIA IN MENDELIAN SUSCEPTIBILITY 
TO MYCOBACTERIAL DISEASE ASSOCIATED WITH 
A NOVEL MUTATION
Francisco Gimenez-Sanchez, MD, PhD,*  
Elena Cobos-Carrascosa, MD,*  
Miguel Sanchez-Forte, MD, PhD,*  
Miguel Martinez-Lirola, MD, PhD,†  
Encarnacion Lopez-Ruzafa, MD,*  
Rafael Galera-Martinez, MD,*  
Teresa Del Rosal-Babes, MD,‡ and  
Monica Martinez-Gallo, PhD§
Abstract: Deficiency in the interleukin12/INFgamma pathway is a genetic 
condition that predisposes to some infections, including nontuberculous 
mycobacteria infection and extraintestinal salmonellosis. We report 2 cases 
in sisters who were diagnosed with a genetic defect caused by a new muta-
tion in Interleukin-12 receptor β1 chain (IL12Rβ1) leading to different 
clinical presentations and responses to therapy.  
Key Words: immunodeficiency, mycobacterial infection, genetic mutation, 
interleukin, interferon 
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